BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35766529)

  • 1. Where are the older adults? Age distribution of nail psoriasis randomized clinical trials' participants: a systematic review.
    Ricardo JW; Lipner SR
    Int J Dermatol; 2022 Oct; 61(10):e363-e364. PubMed ID: 35766529
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to "Where are the older adults? Age distribution of nail psoriasis-randomized clinical trials' participants: a systematic review" by Ricardo JW et al.
    Megna M; Camela E; Ruggiero A; Fabbrocini G; Potestio L
    Int J Dermatol; 2022 Oct; 61(10):e364-e365. PubMed ID: 35933717
    [No Abstract]   [Full Text] [Related]  

  • 3. Nail Psoriasis in Older Adults: Epidemiology, Diagnosis, and Topical Therapy.
    Ricardo JW; Lipner SR
    Dermatol Clin; 2021 Apr; 39(2):183-193. PubMed ID: 33745632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and management of nail psoriasis].
    Sánchez-Regaña M; Umbert P
    Actas Dermosifiliogr; 2008; 99(1):34-43. PubMed ID: 18206085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional analysis of web-based patient education materials on nail psoriasis.
    Sharma D; Lipner S
    Int J Dermatol; 2023 May; 62(5):e288-e291. PubMed ID: 35239978
    [No Abstract]   [Full Text] [Related]  

  • 6. Nail Psoriasis: A Systematic Evaluation in 313 Children with Psoriasis.
    Pourchot D; Bodemer C; Phan A; Bursztejn AC; Hadj-Rabia S; Boralevi F; Miquel J; Hubiche T; Puzenat E; Souillet AL; Kupfer I; Piram M; Beauchet A; Mahé E;
    Pediatr Dermatol; 2017 Jan; 34(1):58-63. PubMed ID: 27873356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAIL DYSTROPHIES.
    SAMMAN PD
    Trans St Johns Hosp Dermatol Soc; 1963; 49():39-43. PubMed ID: 14050506
    [No Abstract]   [Full Text] [Related]  

  • 8. Nail Psoriasis in Older Adults: Intralesional, Systemic, and Biological Therapy.
    Ricardo JW; Lipner SR
    Dermatol Clin; 2021 Apr; 39(2):195-210. PubMed ID: 33745633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis.
    Starace M; Alessandrini A; Iorizzo M; D'Altobrando A; Ferrari T; Bruni F; Piraccini BM
    Clin Exp Dermatol; 2022 Jun; 47(6):1165-1168. PubMed ID: 35118697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.
    Reich K; Baraliakos X; Coates LC; Elewski B; Bao W; Kasparek T; Gaillez C; Pournara E; Aassi M; Perella C; Gottlieb AB
    Br J Dermatol; 2022 Sep; 187(3):438-441. PubMed ID: 35257363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Nail Lichen Planus: Epidemiology, Pathogenesis, Diagnosis, and Treatment.
    Gupta MK; Lipner SR
    Dermatol Clin; 2021 Apr; 39(2):221-230. PubMed ID: 33745635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed analysis of specific nail psoriasis features and their correlations with clinical parameters: a cross-sectional study.
    Kyriakou A; Patsatsi A; Sotiriadis D
    Dermatology; 2011; 223(3):222-9. PubMed ID: 22085812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to choose a systemic treatment for moderate-to-severe nail psoriasis.
    Rigopoulos D; Rompoti N; Tsiogka A; Lipner SR
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e1034-e1041. PubMed ID: 35841301
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysbiosis of nail microbiome in patients with psoriasis.
    Wang S; Wang R; Song Y; Wan Z; Chen W; Li H; Li R
    Exp Dermatol; 2022 May; 31(5):800-806. PubMed ID: 35028964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-To-Severe Psoriasis.
    Rich P; Goldblum O; Disch D; Lin CY; Merola JF; Elewski B
    J Drugs Dermatol; 2020 Aug; 19(8):741-746. PubMed ID: 32845588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of risankizumab on nail psoriasis in patients with active psoriatic arthritis: results from KEEPsAKE 1.
    Kristensen LE; Soliman AM; Papp K; Merola JF; Barcomb L; Wang Z; Eldred A; Behrens F
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e389-e392. PubMed ID: 35032356
    [No Abstract]   [Full Text] [Related]  

  • 17. Subclinical enthesitis in nail psoriasis patients: a case-control study.
    Klaassen KM; Ploegmakers MJ; van de Kerkhof PC; Klein WM; Pasch MC
    J Dtsch Dermatol Ges; 2017 Apr; 15(4):405-412. PubMed ID: 28378489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment.
    Grynszpan R; Barreiros G; do Nascimento Paixão M; Frasnelli Fernandes M; Aguinaga F; Camargo C; Ramos-E-Silva M; Carneiro S
    Mycoses; 2021 Sep; 64(9):1092-1097. PubMed ID: 34061419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nail involvement can predict enthesopathy in patients with psoriasis.
    Castellanos-González M; Joven BE; Sánchez J; Andrés-Esteban EM; Vanaclocha-Sebastián F; Romero PO; Díaz RR
    J Dtsch Dermatol Ges; 2016 Nov; 14(11):1102-1107. PubMed ID: 27860304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for nail psoriasis.
    de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.